Keywords: ceragenix, enters, mrsa, bird, flu, accord, usa
Ceragenix enters MRSA and bird flu R&D accord
Article | 03 July 2006
The USA's Ceragenix Pharmaceuticals has entered into an R&D agreement with an internationally-recognized undisclosed research laboratory to develop formulations, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
